Diagnosis and Treatment > Signs and Symptoms > Ventricular fibrillation

You are looking at 1 - 2 of 2 items

Anna Popławska-Kita Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Anna Popławska-Kita in
Google Scholar
PubMed
Close
,
Marta Wielogórska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Marta Wielogórska in
Google Scholar
PubMed
Close
,
Łukasz Poplawski Radiology, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Łukasz Poplawski in
Google Scholar
PubMed
Close
,
Katarzyna Siewko Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Close
,
Agnieszka Adamska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Close
,
Piotr Szumowski Departments of Nuclear Medicine, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Piotr Szumowski in
Google Scholar
PubMed
Close
,
Piotr Myśliwiec 1st Clinic Department of General and Endocrine Surgery, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Piotr Myśliwiec in
Google Scholar
PubMed
Close
,
Janusz Myśliwiec Departments of Nuclear Medicine, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Janusz Myśliwiec in
Google Scholar
PubMed
Close
,
Joanna Reszeć Departments of Medical Pathomorphology, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Joanna Reszeć in
Google Scholar
PubMed
Close
,
Grzegorz Kamiński Department of Endocrinology and Radioisotopy Therapy, Military Institute of Medicine, Warsaw, Poland

Search for other papers by Grzegorz Kamiński in
Google Scholar
PubMed
Close
,
Janusz Dzięcioł Departments of Human Anatomy, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Janusz Dzięcioł in
Google Scholar
PubMed
Close
,
Dorota Tobiaszewska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Dorota Tobiaszewska in
Google Scholar
PubMed
Close
,
Małgorzata Szelachowska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Close
, and
Adam Jacek Krętowski Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
Close

Summary

Papillary thyroid gland carcinoma is the most common type of malignancy of the endocrine system. Metastases to the pituitary gland have been described as a complication of papillary thyroid cancer in few reported cases since 1965. We report the case of a 68-year-old female patient with a well-differentiated form of thyroid gland cancer. Despite it being the most common malignant cancer of the endocrine system, with its papillary form being one of the two most frequently diagnosed thyroid cancers, the case we present is extremely rare. Sudden cardiac arrest during ventricular fibrillation occurred during hospitalization. Autopsy of the patient revealed papillary carcinoma of the thyroid, follicular variant, with metastasis to the sella turcica, and concomitant sarcoidosis of heart, lung, and mediastinal and hilar lymph nodes. Not only does atypical metastasis make our patient’s case most remarkable, but also the postmortem diagnosis of sarcoidosis makes her case particularly unusual.

Learning points:

  • The goal of presenting this case is to raise awareness of the clinical heterogeneity of papillary cancer and promote early diagnosis of unexpected metastasis and coexisting diseases to improve clinical outcomes.

  • Clinicians must be skeptical. They should not fall into the trap of diagnostic momentum or accept diagnostic labels at face value. Regardless of the potential mechanisms, clinicians should be aware of the possibility of the coexistence of thyroid cancer and sarcoidosis as a differential diagnosis of lymphadenopathy.

  • This case highlights the importance of the diagnostic and therapeutic planning process and raises awareness of the fact that one uncommon disease could be masked by another extremely rare disorder.

Open access
Varalaxmi Bhavani Nannaka Division of Pulmonary and Critical Care Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA

Search for other papers by Varalaxmi Bhavani Nannaka in
Google Scholar
PubMed
Close
and
Dmitry Lvovsky Division of Pulmonary and Critical Care Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA

Search for other papers by Dmitry Lvovsky in
Google Scholar
PubMed
Close

Summary

Angina pectoris in pregnancy is unusual and Prinzmetal’s angina is much rarer. It accounts for 2% of all cases of angina. It is caused by vasospasm, but the mechanism of spasm is unknown but has been linked with hyperthyroidism in some studies. Patients with thyrotoxicosis-induced acute myocardial infarction are unusual and almost all reported cases have been associated with Graves’ disease. Human chorionic gonadotropin hormone-induced hyperthyroidism occurs in about 1.4% of pregnant women, mostly when hCG levels are above 70–80 000 IU/L. Gestational transient thyrotoxicosis is transient and generally resolves spontaneously in the latter half of pregnancy, and specific antithyroid treatment is not required. Treatment with calcium channel blockers or nitrates reduces spasm in most of these patients. Overall, the prognosis for hyperthyroidism-associated coronary vasospasm is good. We describe a very rare case of an acute myocardial infarction in a 27-year-old female, at 9 weeks of gestation due to right coronary artery spasm secondary to gestational hyperthyroidism with free thyroxine of 7.7 ng/dL and TSH <0.07 IU/L.

Learning points:

  • AMI and cardiac arrest due to GTT despite optimal medical therapy is extremely rare.

  • Gestational hyperthyroidism should be considered in pregnant patients presenting with ACS-like symptoms especially in the setting of hyperemesis gravidarum.

  • Our case highlights the need for increased awareness of general medical community that GTT can lead to significant cardiac events. Novel methods of controlling GTT as well as medical interventions like ICD need further study.

Open access